What a yes vote endorsed
Kay Hagan Tick Act Reauthorization
Official title: To reauthorize the Kay Hagan Tick Act, and for other purposes.
What this does
Congress reauthorizes two vector-borne disease programs under the Public Health Service Act through 2030. It extends the authorization of appropriations for the national strategy and regional centers of excellence in vector-borne disease from the 2021 through 2025 window to 2026 through 2030. It makes the same extension for the program that provides enhanced support to state and local health departments addressing vector-borne diseases. The bill also removes a specific reference to the Tick-Borne Disease Working Group in the strategy provision and replaces it with appropriate individuals, and it adds language directing that the work include increasing capacity to identify, report, prevent, and respond to such diseases.
Passed the House by voice vote
How we know · 6 sourced claims
- Congress reauthorizes two vector-borne disease programs under the Public Health Service Act through 2030.Source: Sec. 1(a), Sec. 1(b)
- It extends the authorization of appropriations for the national strategy and regional centers of excellence in vector-borne disease from the 2021 through 2025 window to 2026 through 2030.Source: Sec. 1(a)(3)
- It makes the same extension for the program that provides enhanced support to state and local health departments addressing vector-borne diseases.Source: Sec. 1(b)
- The bill removes a specific reference to the Tick-Borne Disease Working Group in the strategy provision and replaces it with appropriate individuals.Source: Sec. 1(a)(1)
- It adds language directing that the work include increasing capacity to identify, report, prevent, and respond to such diseases.Source: Sec. 1(a)(2)
- Every provision amends the Public Health Service Act to reauthorize and adjust the Kay Hagan Tick Act's vector-borne disease programs.Source: Sec. 1
Reported lobbying
At least
2
organizations named this measure in a lobbying filing.
A floor, not a total. Those organizations were counted by the client name on 2 quarterly reports filed by 1 registered lobbying firm in 2026 Q2. The disclosure form takes a free text description of the issue, so an organization that lobbied this measure without naming it is not counted here.
The filings record that lobbying was reported on the measure. They carry no per-bill dollar figure and no position, so nothing here says how much was spent or which side an organization took.
From the LD-2 quarterly lobbying filings published at lda.gov by the Senate Office of Public Records. Read for 2025 Q1, 2025 Q2, 2025 Q3, 2025 Q4, 2026 Q1 and 2026 Q2. The pull came up 2 short in 2025 Q4 and 7 short in 2026 Q2 against the register's own count, so those quarters are the filings posted rather than every one filed. 2026 Q3 is still inside its filing window, so that quarter is only the filings posted so far.